- active not recruitingPHASE1, PHASE2
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
This study is looking at new drug combinations for advanced cancers like ovarian, breast, lung, and stomach cancer. It checks how safe and effective they are, and how they work in the body.
United States · France · Israel - authorisedPhase II and Phase III (Integrated)
68Ga-FAPI-46 PET for imaging of gastrointestinal cancers: A prospective interventional single-arm clinical trial (FAPI-PET-GI)
This study is testing a new type of scan, called a 68Ga-FAPI-46 PET scan, to see how well it finds different types of gut cancers. It compares the new scan to standard methods to see if it improves detection.
Germany